TAMPA, Fla. & MONTREAL--(BUSINESS WIRE)--UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), a specialty finance company focused on technology transfer, and Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics company developing high-value human proteins, today announced the signing of a technology acquisition alliance.
